Article source: ConstructConnect
- The degree to which the coronavirus vaccine development process is being compressed (i.e., from ten years or more to one year or less) raises an abundance of ethical issues. Human volunteers for clinical trials are being exposed to unknown dangers and side effects.
- The least questionable trial methodology ‒ assuming such a thing can be placed on a sliding scale ‒ monitors the results when inoculated subjects simply continue to live, as per usual, among a general population that’s been infected. If, however, there is positive progress in lowering the infection rate of the population at large by non-vaccine means, it will make it harder to obtain reliable results from the test group. Ironic, right? Therefore, the test group may need to be chosen from a location where the coronavirus infection rate is still climbing or near its peak.
